Frazier Life Sciences Management, L.P. - HILLEVAX INC ownership

HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$131,560,798
-21.8%
9,781,4720.0%8.74%
-13.0%
Q2 2023$168,143,504
+4.0%
9,781,4720.0%10.04%
-14.2%
Q1 2023$161,687,732
-1.0%
9,781,472
+0.2%
11.71%
+15.3%
Q4 2022$163,257,346
-2.1%
9,758,3590.0%10.15%
-21.0%
Q3 2022$166,770,000
+64.3%
9,758,359
+5.1%
12.84%
+34.1%
Q2 2022$101,493,0009,285,6829.58%
Other shareholders
HILLEVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$9,350,78212.37%
Frazier Life Sciences Management, L.P. 9,758,359$163,257,34610.15%
Abingworth LLP 1,838,486$30,757,87110.02%
Samsara BioCapital, LLC 610,062$10,206,3372.20%
StepStone Group LP 676,567$11,318,9661.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,694,101$45,072,3100.93%
BRAIDWELL LP 1,620,216$27,106,2140.91%
RA Capital Management 1,760,019$29,445,1180.60%
Perceptive Advisors 406,024$6,792,7820.19%
BVF INC/IL 248,579$4,158,7270.18%
View complete list of HILLEVAX INC shareholders